Allogeneic Hematopoietic Cell Transplantation (HCT) with Nonmyeloablative Conditioning after Failed Myeloablative HCT: Factors Affecting Outcomes.
Frédéric Baron(University of Liège), Brenda M. Sandmaier(University of Washington), Judith A. Shizuru(Stanford University), David G. Maloney(Fred Hutch Cancer Center), Benedetto Bruno(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Stephen J. Forman(City Of Hope National Medical Center), Dietger Niederwieser(Leipzig University of Applied Sciences), Edward Agura(Baylor University Medical Center), Barry E. Storer(City Of Hope National Medical Center), Mike A. Pulsipher(Primary Children's Hospital), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), R. Maziarz(Oregon Health & Science University), Peter A. McSweeney(Mesoblast (United States)), T Chauncey, Michael Maris(Sarah Cannon), James C. Wade(Medizinische Hochschule Hannover), Mohamed L. Sorror(University of Washington Medical Center)
Cited by 1
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2014|2.7k